Polartechnics lands distribution deal for US laser product
Thursday, 18 August, 2005
Sydney-based Polartechnics (ASX:PLT) has signed an exclusive agreement with Reliant Technologies to distribute the California-based company's Fraxel laser product range in Australia, New Zealand and Oceania.
Reliant's Fraxel laser product treats the skin fractionally with patterns of microscopic laser spots, resulting in a unique wound healing process.
Polartechnics has completed the TGA listing process and Fraxel treatments are already available in three Australian locations.
"We anticipate this product range will make a significant contribution to our ongoing revenue growth," said Polartechnics' chairman Robert Hunter in a statement.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
